PACB vs. SPY
Compare and contrast key facts about Pacific Biosciences of California, Inc. (PACB) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PACB or SPY.
Correlation
The correlation between PACB and SPY is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PACB vs. SPY - Performance Comparison
Key characteristics
PACB:
-0.23
SPY:
0.51
PACB:
0.43
SPY:
0.86
PACB:
1.04
SPY:
1.13
PACB:
-0.26
SPY:
0.55
PACB:
-0.79
SPY:
2.26
PACB:
32.58%
SPY:
4.55%
PACB:
110.72%
SPY:
20.08%
PACB:
-97.87%
SPY:
-55.19%
PACB:
-97.87%
SPY:
-9.89%
Returns By Period
In the year-to-date period, PACB achieves a -40.44% return, which is significantly lower than SPY's -5.76% return. Over the past 10 years, PACB has underperformed SPY with an annualized return of -15.11%, while SPY has yielded a comparatively higher 11.99% annualized return.
PACB
-40.44%
-14.17%
-38.42%
-21.01%
-19.52%
-15.11%
SPY
-5.76%
-3.16%
-4.30%
10.76%
15.96%
11.99%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PACB vs. SPY — Risk-Adjusted Performance Rank
PACB
SPY
PACB vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacific Biosciences of California, Inc. (PACB) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PACB vs. SPY - Dividend Comparison
PACB has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.30%.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
PACB Pacific Biosciences of California, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.30% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
PACB vs. SPY - Drawdown Comparison
The maximum PACB drawdown since its inception was -97.87%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for PACB and SPY. For additional features, visit the drawdowns tool.
Volatility
PACB vs. SPY - Volatility Comparison
Pacific Biosciences of California, Inc. (PACB) has a higher volatility of 30.98% compared to SPDR S&P 500 ETF (SPY) at 15.12%. This indicates that PACB's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.